At 1 year after transcatheter aortic valve replacement (TAVR), patients treated with contemporary balloon-expandable valves (BEVs) and self-expanding valves (SEVs) showed similar rates of all-cause mortality, significant paravalvular leak and permanent pacemaker implantation, but patients treated with BEVs showed a higher rate of stroke, according to study results presented Friday at the TCT Connect virtual conference.